UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056666
Receipt number R000064622
Scientific Title A Qualitative Study of Psychosocial Support for Patients and Families After Hematopoietic Stem Cell Transplantation Visiting Multiple Outpatient Clinics
Date of disclosure of the study information 2025/01/14
Last modified on 2025/01/08 17:15:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Qualitative Study of Psychosocial Support for Patients and Families After Hematopoietic Stem Cell Transplantation Visiting Multiple Outpatient Clinics

Acronym

A Study of Psychosocial Support for Patients and Families After Hematopoietic Stem Cell Transplantation

Scientific Title

A Qualitative Study of Psychosocial Support for Patients and Families After Hematopoietic Stem Cell Transplantation Visiting Multiple Outpatient Clinics

Scientific Title:Acronym

A Study of Psychosocial Support for Patients and Families After Hematopoietic Stem Cell Transplantation

Region

Japan


Condition

Condition

Patients who received auto/allo hematopoietic stem cell transplant

Classification by specialty

Hematology and clinical oncology Pediatrics Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify the situations, contents, and needs of psychological and social support for patients and families who received hematopoietic stem cell transplantation during childhood.

Basic objectives2

Others

Basic objectives -Others

To identify the support that their patients and family members need.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Situations, contents and needs of psychological and social support for patients and family members

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Outpatients (12 years of age or older) who received auto/allo hematopoietic stem cell transplant and their family members who have been in remission for at least one year

Key exclusion criteria

Unsuitability for participation due to the participant's physical or mental health, as determined by pediatricians

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Shohei
Middle name
Last name Nakajima

Organization

Teikyo University

Division name

Department of Nursing, Faculty of Medical Technology

Zip code

173-8605

Address

2-11-1 Kaga, Itabashi, Tokyo

TEL

+81-3-3964-1211

Email

shoheinf@gmail.com


Public contact

Name of contact person

1st name Shohei
Middle name
Last name Nakajima

Organization

The University of Tokyo Hospital

Division name

Nursing Department

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo, Tokyo

TEL

+81-3-3964-1211

Homepage URL


Email

shoheinf@gmail.com


Sponsor or person

Institute

Teikyo University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

The University of Tokyo Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, the Faculty of Medicine and Graduate School of Medicine of the University of Tokyo and the University of Tokyo Hospital

Address

7-3-1 Hongo, Bunkyo, Tokyo

Tel

+81-3-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 12 Month 31 Day

Date of IRB

2024 Year 12 Month 04 Day

Anticipated trial start date

2025 Year 01 Month 14 Day

Last follow-up date

2025 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a cross-sectional survey combined with semi-structured interviews and medical records.


Management information

Registered date

2025 Year 01 Month 08 Day

Last modified on

2025 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064622